RNTX

Rein Therapeutics Inc.$0.96+0.03 (+3.67%)

Prev Close$0.93·MCap$31.5M·P/E—·Vol691.7K·Yield—

▲

Buys (12M)

$74.6K

▼

Sells (12M)

$0.00

◆

Net Activity

Net Buyer

$74.6K

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Rein Therapeutics Inc. (RNTX) has been exclusively buying, with 2 insider purchases totaling $74.6K and 0 insider sales totaling $0.00. The most recent insider transaction was by VON RICKENBACH JOSEF H (director), who purchased $49.6K worth of shares on May 28, 2026. Rein Therapeutics Inc. operates in the Healthcare sector, within the Medical - Pharmaceuticals industry, with a market cap of $31.5M.

RNTX Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
May 28, 2026	VON RICKENBACH JOSEF H	director	Buy	47,060	$1.05	$49.6K	62,514+305%
May 13, 2026	WINDSOR JAMES BRIAN	director, officer: See Remarks	Buy	25,000	$1.00	$25.0K	27,046New Position
Dec 9, 2024	WINDSOR JAMES BRIAN	President and CEO	Buy	400	$2.24	$897.61	239
Jun 17, 2024	UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO	10% Owner	Sell	6,607	$3.26	$21.6K	1,751,256
Jun 12, 2024	UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO	10% Owner	Sell	24,671	$3.27	$80.7K	1,768,250
Jun 7, 2024	UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO	10% Owner	Sell	12,315	$3.29	$40.5K	1,783,851
May 1, 2024	UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO	10% Owner	Sell	31,151	$4.47	$139.1K	1,803,777
Dec 18, 2023	WINDSOR JAMES BRIAN	President and COO	Buy	225	$3.37	$758.25	225
Nov 21, 2023	WINDSOR JAMES BRIAN	President and COO	Buy	5,076	$1.97	$10.0K	5,122New Position

RNTX Insider Buying Activity

The following table shows recent insider purchases of Rein Therapeutics Inc. (RNTX) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
May 28, 2026	VON RICKENBACH JOSEF H	director	Buy	47,060	$1.05	$49.6K	62,514+305%
May 13, 2026	WINDSOR JAMES BRIAN	director, officer: See Remarks	Buy	25,000	$1.00	$25.0K	27,046New Position
Dec 9, 2024	WINDSOR JAMES BRIAN	President and CEO	Buy	400	$2.24	$897.61	239
Dec 18, 2023	WINDSOR JAMES BRIAN	President and COO	Buy	225	$3.37	$758.25	225
Nov 21, 2023	WINDSOR JAMES BRIAN	President and COO	Buy	5,076	$1.97	$10.0K	5,122New Position

RNTX Insider Selling Activity

The following table shows recent insider sales of Rein Therapeutics Inc. (RNTX) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jun 17, 2024	UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO	10% Owner	Sell	6,607	$3.26	$21.6K	1,751,256
Jun 12, 2024	UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO	10% Owner	Sell	24,671	$3.27	$80.7K	1,768,250
Jun 7, 2024	UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO	10% Owner	Sell	12,315	$3.29	$40.5K	1,783,851
May 1, 2024	UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO	10% Owner	Sell	31,151	$4.47	$139.1K	1,803,777